Skip to main content
    B

    BeOne Medicines AG (ONC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $411.29
    -5.25 (-1.26%)

    Market Cap: $47.58B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    BeOne Medicines AG (ONC) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to BeOne Medicines AG are Genmab AS (GMAB), argenx NV ADR (ARGX) and Regeneron Pharmaceuticals (REGN). BeOne Medicines AG trades at 50.0x earnings, against a median of 30.0x for the 7 of these companies with a P/E. By market cap, BeOne Medicines AG ranks 5th of the 13 companies on this page; Vertex Pharmaceuticals (VRTX) is the largest at $136.56B.

    Peer Comparison

    ONC's ROIC of 7.5% is above the peer median of 4.8%, and its revenue growth of 33.8% is above the median of 32.8%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    BeOne Medicines AG (ONC)$47.58B50.0x18.7x13.9%7.5%33.8%0.00%
    Genmab AS (GMAB)$31.67B35.8x19.2x17.0%4.8%16.1%0.00%
    argenx NV ADR (ARGX)$60.37B33.5x6.1x31.7%N/A52.1%0.00%
    Regeneron Pharmaceuticals Inc (REGN)$98.84B18.4x5.7x28.5%13.7%36.3%0.39%
    BridgeBio Pharma Inc (BBIO)$15.25BN/A16.0x-59.8%-33.0%192.6%0.00%
    Revolution Medicines Inc (RVMD)$37.27BN/A181.6x0.0%-52.1%-95.2%0.00%
    Royalty Pharma Plc (RPRX)$39.85B12.9x11.7x25.7%7.6%13.3%1.37%
    Insmed Inc (INSM)$26.58BN/A17.7x-39.9%-44.2%268.4%0.00%
    Roivant Sciences Ltd (ROIV)$28.64BN/A679.3x0.0%N/A2136.0%0.00%
    Moderna Inc (MRNA)$90.38BN/A34.2x-110.5%-28.9%29.2%0.00%
    Exelixis Inc (EXEL)$16.84B19.3x6.9x35.4%N/A10.2%0.00%
    Vertex Pharmaceuticals Inc (VRTX)$136.56B30.0x10.5x30.7%14.2%11.8%0.00%
    TG Therapeutics Inc (TGTX)$9.75B87.2x11.1x11.8%11.0%60.7%0.00%
    Peer median$34.47B30.0x13.9x14.4%4.8%32.8%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to BeOne Medicines AG, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Genmab AS (GMAB)
    Genmab A / S develops antibody therapies for the treatment of cancer and other diseases mainly in Denmark. The company is headquartered in Copenhagen, Denmark.
    GMAB competitors
    argenx NV ADR (ARGX)
    argenx SE, a clinical-phase biotechnology company, focuses on the development of antibody-based therapies for the treatment of autoimmune diseases...
    ARGX competitors
    Regeneron Pharmaceuticals Inc (REGN)
    Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.
    REGN competitors
    BridgeBio Pharma Inc (BBIO)
    BridgeBio Pharma, Inc. is dedicated to the discovery, development and supply of various drugs for genetic diseases.
    BBIO competitors
    Revolution Medicines Inc (RVMD)
    Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted...
    RVMD competitors
    Royalty Pharma Plc (RPRX)
    Royalty Pharma plc is a buyer of biopharmaceutical royalties and funder of innovations in the biopharmaceutical industry in the United States.
    RPRX competitors
    Insmed Inc (INSM)
    Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases.
    INSM competitors
    Roivant Sciences Ltd (ROIV)
    Roivant Sciences Ltd (ROIV) is a transformative biopharmaceutical company focused on advancing drug development and commercialization through a distinctive...
    ROIV competitors
    Moderna Inc (MRNA)
    Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology...
    MRNA competitors
    Exelixis Inc (EXEL)
    Exelixis, Inc., an oncology-focused biotechnology company, is focused on the discovery, development...
    EXEL competitors
    Vertex Pharmaceuticals Inc (VRTX)
    Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
    VRTX competitors
    TG Therapeutics Inc (TGTX)
    TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development...
    TGTX competitors

    Frequently Asked Questions About ONC

    Who are BeOne Medicines AG's main competitors?

    The companies most similar to BeOne Medicines AG include Genmab AS (GMAB), argenx NV ADR (ARGX), Regeneron Pharmaceuticals (REGN), BridgeBio Pharma (BBIO) and Revolution Medicines (RVMD), listed from the closest match.

    Who is BeOne Medicines AG's biggest competitor?

    Vertex Pharmaceuticals (VRTX) is the largest of the similar companies at $136.56B; Genmab AS (GMAB) is the closest match by business profile, size, sector and industry.

    How does ONC stock compare with its competitors?

    ONC's P/E is 50.0x against a peer median of 30.0x; its P/S is 18.7x against a peer median of 13.9x; its net margin is 13.9% against a peer median of 14.4%.

    Which of BeOne Medicines AG's competitors pays a higher dividend?

    BeOne Medicines AG pays no dividend. Royalty Pharma Plc (RPRX) and Regeneron Pharmaceuticals (REGN) have higher forward dividend yields; Royalty Pharma Plc (RPRX) has the highest at 1.37%.

    Is BeOne Medicines AG bigger than its competitors?

    No. BeOne Medicines AG is 5th by market cap among the 13 companies on this page; the largest is Vertex Pharmaceuticals (VRTX) at $136.56B.